Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease-Reference-Cited by-同舟云学术

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease

Published:2021-10-04 Issue:11 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Tarallo Antonietta¹²,Damiano Carla¹²,Strollo Sandra¹^ORCID,Minopoli Nadia¹²^ORCID,Indrieri Alessia¹³^ORCID,Polishchuk Elena¹,Zappa Francesca¹,Nusco Edoardo¹,Fecarotta Simona²,Porto Caterina²,Coletta Marcella²,Iacono Roberta⁴⁵^ORCID,Moracci Marco⁴⁵,Polishchuk Roman¹^ORCID,Medina Diego Luis¹²^ORCID,Imbimbo Paola⁶,Monti Daria Maria⁶,De Matteis Maria Antonietta¹⁷^ORCID,Parenti Giancarlo¹²^ORCID

Affiliation:

1. Telethon Institute of Genetics and Medicine Pozzuoli Italy

2. Department of Translational Medical Sciences Federico II University Naples Italy

3. Institute for Genetic and Biomedical Research (IRGB) National Research Council (CNR) Milan Italy

4. Department of Biology University of Naples "Federico II", Complesso Universitario di Monte S. Angelo Naples Italy

5. Institute of Biosciences and BioResources ‐ National Research Council of Italy Naples Italy

6. Department of Chemical Sciences Federico II University Naples Italy

7. Department of Molecular Medicine and Medical Biotechnologies Federico II University Naples Italy

Funder

Spark Therapeutics

Fondazione Telethon

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202114434

Reference101 articles.

1. Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells

2. Lysosomes as dynamic regulators of cell and organismal homeostasis

3. Rapamycin and mTOR kinase inhibitors

4. Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease

5. Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy;Molecular Diagnosis & Therapy;2024-08-12

2. Intravital imaging of muscle damage and response to therapy in a model of Pompe disease;Clinical and Translational Medicine;2024-03

3. How dietary advanced glycation end products could facilitate the occurrence of food allergy;Journal of Allergy and Clinical Immunology;2023-11

4. New and little-known possibilities of edaravone in the treatment of cerebral stroke and extracranial pathology;Infusion & Chemotherapy;2023-09-29

5. A Comprehensive Update on Late-Onset Pompe Disease;Biomolecules;2023-08-22